Double Blind, Placebo Controlled, Parallel Group Study With an Open Label Reference Arm to Assess the Effects of Intravenously Administered AIN457 on Ozone Induced Neutrophilia Compared to Placebo and Oral Corticosteroid in Healthy Volunteers.
Phase of Trial: Phase I/II
Latest Information Update: 05 Sep 2012
At a glance
- Drugs Secukinumab (Primary) ; Prednisolone
- Indications Ankylosing spondylitis; Asthma; Crohn's disease; Multiple sclerosis; Plaque psoriasis; Polymyalgia rheumatica; Psoriatic arthritis; Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Novartis Pharmaceuticals
- 05 Sep 2012 Results presented at the 22nd Annual Congress of the European Respiratory Society.
- 10 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History